Pharmaceuticals Embraces AI: Who Is Constraining Its Risks?

Written by

in

An ACTO report says pharmaceutical and biotechnology companies are adopting AI faster than they are building corporate governance. More than one-third of respondents lack clear internal governance or rely only on one-off IT approvals. 23% of respondents do not monitor or discuss employees’ use of unauthorized AI agents, while 58% believe the industry still lacks clear standards for responsible AI use. Governance approaches that emphasize the human factor perform better in adoption, trust, value, and ROI measurement.

Source:Pharma Industry News · Read Original

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *